Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Not a good PR plan by Ate. Now officially pis sed off
View:
Post by YukonJezza on Feb 25, 2021 9:54am

Not a good PR plan by Ate. Now officially pis sed off

Comment by MikeStock on Feb 25, 2021 10:07am
When have you ever seen a good PR plan from these guys?  I would expect that they meet to look at all of the news they have coming out and release it in a way that creates momentum. I've been a CMO of mid-sized tech companies for years and this is what I do with my team. I don't understand how they continue to operate their news strategy like this. 
Comment by Candyswanwick on Feb 25, 2021 10:52am
Are you off your rocker? The deal was done very well and we are still sitting up considerably off of our lows? This post actually made me laugh out loud.
Comment by Amigo11 on Feb 25, 2021 11:03am
Oh good for you-laugh it up Mr Sanctimonious-the stock price cant hold the recent issue terms-laugh it off !!!!
Comment by Candyswanwick on Feb 25, 2021 11:08am
Is it normal to hold the issue price? Lol NO. 
Comment by Amigo11 on Feb 25, 2021 12:11pm
Sure it is normal to hold the issue price LOL ridiculous comment
Antibe Therapeutics Inc(Pre-Merger)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested